Targeted antibiotics could delay emergence of resistant Neisseria gonorrhoeae. The DNA gyrase subunit A assay predicts susceptibility to ciprofloxacin. A model found that adding a $50 gyrase subunit A test for asymptomatic patients screened for N. gonorrhoeae resulted in cost neutrality. When ciprofloxacin susceptibility was high, a $114 test resulted in savings.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/OLQ.0000000000001090 | DOI Listing |
Publication Analysis
Top Keywords
neisseria gonorrhoeae
8
dna gyrase
8
gyrase subunit
8
addressing neisseria
4
gonorrhoeae treatment
4
treatment resistance
4
resistance dna
4
gyrase assay
4
assay economic
4
economic study
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!